期刊文献+

2-甲氧基雌二醇合成方法的改进 被引量:3

An Improved Synthetic Method of 2-Methoxyestradiol
下载PDF
导出
摘要 目的 合成抗肿瘤新药新生血管形成抑制剂 2 甲氧基雌二醇。方法 以雌二醇为原料经 2 位溴代 ,继而甲氧基化直接合成 2 甲氧基雌二醇。结果 改进的合成方法割除了文献报道方法中的 3,17 双乙酰化及水解二个反应步骤 ,合成获得的 2 甲氧基雌二醇成品进行了结构确证。结论 通过有效地纯化 2 溴雌二醇中间体 ,可缩短二步反应直接制得成品。 Purpose: To synthesize a new antitumor drug 2-methoxyestradiol which is an angiogenesis inhibitor. Methods: 2-methoxyestradiol was directly synthesized by 2-bromination followed methoxylation from estradiol. Results: Compared with reported method, two reaction stages (3, 17-diacetylation and hydrolysis) were omitted in improved synthesis. The structure of obtained 2-methoxyestradiol was confirmed via 1H-NMR and mass spectrum. Conclusions: The two reaction stages in reported synthetic procedure of 2-methoxyestrdiol can be shortened via efficient purification of 2-bromoestradiol intermediate.
出处 《复旦学报(医学版)》 EI CAS CSCD 北大核心 2003年第5期494-495,共2页 Fudan University Journal of Medical Sciences
关键词 2-甲氧基雌二醇 合成方法 抗肿瘤药 2-溴雌二醇 中间体 雌二醇 Alcohols Hydrolysis Nuclear magnetic resonance spectroscopy Purification Tumors
  • 相关文献

参考文献2

共引文献2

同被引文献22

  • 1高巍然,侯健.2-甲氧基雌二醇对骨髓瘤细胞系增殖与凋亡的影响[J].中国实验血液学杂志,2005,13(2):293-297. 被引量:5
  • 2胡启之.OECD新发布急性经口毒性试验方法简介[J].毒理学杂志,2005,19(4):323-325. 被引量:14
  • 3周霞,侯健.2-甲氧基雌二醇诱导HL-60、K562细胞分化作用初探[J].中华血液学杂志,2006,27(1):58-59. 被引量:2
  • 4Dubey R, Jackson E. Potential Vascular Aclions of 2 -Methoxyestradiol. Trends Endocrinol. Metab,2009 ,20 :374 - 379. 被引量:1
  • 5Xu X, Roman J, lssaq H, et al. Quantitative Measurement of Endogenous Estrogens and Estroger/Metabolites in Human Serum by Liquid Chroma - tography - Tandem Mass Spectrometry. Anal. Chem. ,2007,79 :7813 - 7921. 被引量:1
  • 6Liu Z. - J, Zhu B. T. Concentration - dependent Mitogenic and Antiproliferative Actions of 2 - Methoxyestradiol in Estrogen Receptor - positive Human Breast Cancer Cells [J]. Steroid Biochem Mol. Biol. ,2004,88:265 -275. 被引量:1
  • 7Lee I,Choe Y,Jung K. - H,et al, 2 - [ methyl - 11C ] Methoxyestradid:Synthesis,Evaluation and Phmrmacokinetlcs for in Vivo Studies on Angiogenesis. Nucl. Med. Biol. ,2007,34:625-631. 被引量:1
  • 8Dahut W,Lakhani N,Gulley J,et al. Phase I Clinical Trial of Oral 2- Methoxyestradiol, an Antiangiogenic and Apoptotic Agent, in Patients with Solid Tumors. Cancer Biol. Ther. ,2006,5:22-27. 被引量:1
  • 9Sweeney C, Liu G, Yiannoutsos C,et al. Phase II Multicenter, Randomized, Double - Blind, Safety Trial Assessing the Pharma- cokinetics, Pharmacodynamics, and Ef? cacy of Oral 2 - Methoxyestradlol Capsules in Hormone - Refractory Prostate Cancer. Clin. Cancer Res. ,2005,11:6625 -6633. 被引量:1
  • 10khani N, Sparreboom A, Xu X, et 8.1. Characterization of in Vitro and in Vi o Metabolic Pathways of the "Investigational Anticancer Agent ,2 - Methoxyestradiol[ J ]. Pharm. Sci. ,2007,96 : 1821 - 1831. 被引量:1

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部